Viviana Figueroa Diaz

Screening for Non-Alcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the U.S. is Cost Effective: A Comprehensive Cost-Utility Analysis.

D. Dieterich, M. Noureddin, N. Alkhouri, 2020, Gastroenterology.

Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications

Sooah Kim, N. Theise, James S. Park, 2021, The American journal of gastroenterology.